Search research articles
Contact Us
Filters
Showing results (101-110 of 137) with videos related to
Page
of 14
Sort By:
Molecular Cell
|
November 13, 2018
MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis
Manpreet Kalkat, Diana Resetca, Corey Lourenco, et al.
BMC Cancer
|
July 6, 2010
Characterization of the apoptotic response of human leukemia cells to organosulfur compounds
W Wei-Lynn Wong, Paul C Boutros, Amanda R Wasylishen, et al.
The Journal of Biological Chemistry
|
February 14, 2009
Absence of caspase-3 protects pancreatic {beta}-cells from c-Myc-induced apoptosis without leading to tumor formation
Anna Radziszewska, Stephanie A Schroer, Diana Choi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 18, 2009
Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues
Angela B Y Hui, Wei Shi, Paul C Boutros, et al.
Cancer Research Communications
|
June 30, 2026
Association of Cumulative Proton Pump Inhibitor Use with Prostate Cancer Risk and Outcomes: A Population-Based Cohort Study
Rashid K Sayyid, Raj Tiwari, Bo Zhang, et al.
Leukemia
|
July 16, 2020
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
Joseph Longo, Petr Smirnov, Zhihua Li, et al.
Journal of Proteomics
|
December 3, 2014
BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors
Dharmendra Dingar, Manpreet Kalkat, Pak-Kei Chan, et al.
Nature Reviews. Cancer
|
June 30, 2021
MYC protein interactors in gene transcription and cancer
Corey Lourenco, Diana Resetca, Cornelia Redel, et al.
Cancer Research
|
November 21, 2023
Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality
Peter Lin, Corey Lourenco, Jennifer Cruickshank, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 18, 2024
Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation
Diandra Zipinotti Dos Santos, Mohamad Elbaz, Emily Branchard, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 137) with videos related to
Sort By:
Page
of 14
Molecular Cell
|
November 13, 2018
MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis
Manpreet Kalkat, Diana Resetca, Corey Lourenco, et al.
BMC Cancer
|
July 6, 2010
Characterization of the apoptotic response of human leukemia cells to organosulfur compounds
W Wei-Lynn Wong, Paul C Boutros, Amanda R Wasylishen, et al.
The Journal of Biological Chemistry
|
February 14, 2009
Absence of caspase-3 protects pancreatic {beta}-cells from c-Myc-induced apoptosis without leading to tumor formation
Anna Radziszewska, Stephanie A Schroer, Diana Choi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
March 18, 2009
Robust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues
Angela B Y Hui, Wei Shi, Paul C Boutros, et al.
Cancer Research Communications
|
June 30, 2026
Association of Cumulative Proton Pump Inhibitor Use with Prostate Cancer Risk and Outcomes: A Population-Based Cohort Study
Rashid K Sayyid, Raj Tiwari, Bo Zhang, et al.
Leukemia
|
July 16, 2020
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
Joseph Longo, Petr Smirnov, Zhihua Li, et al.
Journal of Proteomics
|
December 3, 2014
BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors
Dharmendra Dingar, Manpreet Kalkat, Pak-Kei Chan, et al.
Nature Reviews. Cancer
|
June 30, 2021
MYC protein interactors in gene transcription and cancer
Corey Lourenco, Diana Resetca, Cornelia Redel, et al.
Cancer Research
|
November 21, 2023
Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality
Peter Lin, Corey Lourenco, Jennifer Cruickshank, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
June 18, 2024
Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation
Diandra Zipinotti Dos Santos, Mohamad Elbaz, Emily Branchard, et al.
Page
of 14